Atlantic salmon (Salmo salar) possess enzymes required for the endogenous biosynthesis of n-3 longchain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), from a-linolenic acid (ALA). Linoleic acid (LA) competes with ALA for LC-PUFA biosynthesis enzymes leading to the production of n-6 LC-PUFA, including arachidonic acid (ARA).
Introduction 1
The omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic (EPA; 2 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids, are recognised as being key essential nutrients 3 in the human diet, providing a range of health benefits through their molecular, cellular and 4 physiological actions (1, 2) . While n-3 LC-PUFA have physiological functions in their own right as key 5 components of cellular membranes (3) and regulators of gene expression (4) , many effects are dependent 6 upon their antagonism of n-6 PUFA, especially arachidonic acid (ARA, 20:4n-6), metabolism (5) . 7
Specifically, both EPA and DHA are precursors of eicosanoids and other highly biologically active 8 derivatives that have important roles in blood homeostasis and the regulation of inflammation, which 9 help to mitigate the pro-inflammatory effects of the high and imbalanced dietary n-6 PUFA content 10 of the Western-type, industrialised diet (6) (7) (8) (9) . Thus, dietary n-3 LC-PUFA are critical in promoting 11 neural development and function (10) (11) , and have beneficial impacts in several pathological conditions 12 including cardiovascular disease, certain inflammatory diseases, and some cancers (12) (13) (14) (15) . 13
Fish and seafood are the major dietary source of n-3 LC-PUFA with so called "oily" fish such as 14
Atlantic salmon (Salmo salar) being one of the best in delivering a physiologically effective dose to 15 human consumers (16) (17) (18) . This is largely due to the primary production of n-3 LC-PUFA being almost 16 exclusively of aquatic origin and thus marine food chains are rich in EPA and DHA with fish 17 accumulating them from their diet (19) (20) (21) . However, global fisheries are at maximum levels of 18 exploitation, and production has stagnated for almost a quarter of a century, with the increasing 19 demand of the burgeoning human population for fish and seafood being met by aquaculture (22) . While 20 over 50 % of all fish and seafood is derived from aquaculture (22) , the n-3 LC-PUFA content of farmed 21 produce could only be guaranteed by basing feeds on fishmeal (FM) and fish oil (FO), which are 22 derived from marine fisheries that are also at sustainable limits (23) . Therefore, FO and FM are finite 23 resources on an annual basis, and their supply would limit aquaculture growth if they were not 24 increasingly replaced in aquafeeds by plant meals and vegetable oils (VO) derived from agriculture (24-25 26) . However, terrestrial plants do not produce LC-PUFA and, consequently, the use of VO in 26 aquaculture has reduced the level of n-3 LC-PUFA in feeds with subsequent impacts on the levels of 27 these nutrients in farmed fish (18, 23) . 28
In contrast, VO can be rich sources of C18 PUFA including both a-linolenic acid (ALA; 18:3n-29
3) and linoleic acid (LA; 18:2n-6) (27) . Atlantic salmon possesses all the genes/enzymes required for 30 the endogenous biosynthesis of both EPA and DHA from ALA (28, 29) . Specifically, salmon have been 31
shown to have fads2 genes, coding for distinct desaturase proteins with separate D6 and D5 activities, 32
and an elovl5 elongase that are necessary for the production of EPA from ALA (30) (31) (32) . The D6 fads2 33 desaturase along with elovl2 and/or elovl4 elongases that are also present enable the production of 34 DHA from EPA (33) (34) . Linoleic acid competes with ALA for the LC-PUFA biosynthesis pathway 35
Sampling 89
At distribution of fish into tanks prior to first feeding, a triplicate sample of 50 -60 alevins (~ 10 g 90 wet weight) were sacrificed by anaesthetic overdose (tricaine methanesulfonate, MS-222; 400 mg.L -91 1 in hydrogen carbonate-buffered solution) prior to being bulk weighed on an electronic top-loading 92 balance to 0.1 g accuracy. The initial samples for compositional analyses were immediately frozen in 93 liquid nitrogen and stored at -70 o C prior to analyses. At the end of the trial after 22 weeks feeding, 94 40 fish per tank were sacrificed by anaesthetic overdose as above prior to being individually weighed 95 on an electronic top-loading balance to 0.1 g accuracy. Twenty whole fish per tank were collected as 96 two pooled samples of 10 fish and immediately frozen in liquid nitrogen and stored at -70 o C prior to 97 analyses. Another 10 fish per tank were sampled for tissues as two pooled samples of 5 fish with 98 samples immediately frozen in liquid nitrogen. Tissues collected were liver, intestine, flesh, gill, brain 99 and eye. A further 10 fish per tank were sacrificed as above and liver collected into RNAlater TM as 100 120 individual samples. These samples were stored overnight at 4 o C before freezing at -70 o C prior 101
to RNA extraction and analysis of gene expression. 102
Lipid and fatty acid analyses 104
Total lipid was extracted from feeds, whole fish, and fish tissues by homogenising in 105 chloroform/methanol (2:1, v/v) using an Ultra-Turrax tissue disrupter (Fisher Scientific, 106
Loughborough, UK), and content determined gravimetrically (39) . Total lipids were resuspended in 107 chloroform/methanol (2:1, v/v) at a concentration of 10 mg.ml -1 . Total phospholipids (PL) and 108 triacylglycerols (TAG) were prepared from total lipid by thin-layer chromatography on silica gel 60 109 plates (20 × 20 cm; Merck KgaA, Darmstadt, Germany) and developed to full distance with 110 isohexane/diethyl ether/acetic acid (85:15:1, by vol.) (40) . Lipid classes were visualised by spraying 111 with 0.1 % (w/v) 2-7-dichlorofluorescein in 97 % aqueous methanol (v/v) and viewing under UV 112 light at 240 nm (UVP ® Mineralight ® R-52G; UVP Inc., San Gabriel, California, USA). Identified 113 classes (TAG and total PL/origin) were scraped into glass tubes and lipids eluted with 114 isohexane/diethyl ether (1:1, v/v). Fatty acid methyl esters (FAME) were prepared from total lipid, 115 total PL and TAG by acid-catalysed transesterification at 50 ˚C for 16 h (41) , and FAME extracted and 116 purified as described previously (42) . FAME were separated and quantified by gas-liquid 117 chromatography using a Restek UK Ltd., Buckinghamshire, UK) and published data (42) . The data were collected and processed 123 using Chromcard for Windows (Version 1.19; Thermoquest Italia S.p.A., Milan, Italy). 124
The within assay precision of this test is based on 6 replicates of the same sample, prepared and 125 analysed at the same time on the same instrumentation, and found to be no greater than 5 % relative 126 S.D. (RSD) across the 12 main fatty acids of interest. Where a difference of > 5 % RSD occurs 127 between within assay replicates the analysis is repeated. Between assay precision is based on 6 128 separate analyses of the same sample at separate time points and the difference across 12 fatty acids 129 found to be no greater than 5 % RSD. 130
131

Liver gene expression 132
Total RNA was extracted from individual liver samples of 10 fish per tank by homogenising in 1 ml 133 of TriReagent® following the producer's protocol (Sigma-Aldrich, Dorset, UK). The quantity and 134 quality of RNA was determined by spectrophotometry (Nanodrop ND-1000; Labtech Int., East 135
Sussex, UK) and RNA integrity assessed by agarose gel electrophoresis. cDNA was synthesised using 136 a high capacity reverse transcription kit utilising 2 μg of total RNA and random primers in a total 137 reaction volume of 20 μl following the manufacturer's protocol (Applied Biosystems, Warrington, 138 UK). The samples were pooled (2 samples of 5 fish per tank) to obtain n = 6 per dietary treatment. A 139 dilution of 1:20 was applied to the resulting cDNA using milliQ water. 140
Expression levels of key genes involved in LC-PUFA biosynthesis pathways (fads2d6, delta-6 fatty 141 acyl desaturase; fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl elongase 2; elovl5a, fatty 142 acyl elongase 5 isoform a; elovl5b, fatty acyl elongase isoform b), lipid biosynthesis (srebp1, sterol 143 regulatory element-binding protein 1; srebp2, sterol regulatory element-binding protein 2; lxr, liver 144 X receptor; fas, fatty acid synthase; hmgcr, HMGCoA reductase) and lipid catabolism (ppara, 145 peroxisome proliferator-activated receptor a; pparg, peroxisome proliferator-activated receptor g; 146 aco, acyl Co-A oxidase; cpt1, carnitine palmitoyl transferase 1) were determined by real-time 147
quantitative RTPCR in liver, as described in detail previously (43) (primers as detailed in 148
Supplementary Table 1) . Results were normalised using reference genes, hypoxanthine guanine 149 phosphoribosyl transferase (hprt), elongation factor 1 alpha (ef1α) and TATA box binding protein 150 (tbp) that were shown as the most stable according to GeNorm (44) stability number (M = 0.239 for 151 ef1a and 0.213 for both hprt and tbp). Primers were designed using Primer 3 and were previously 152 tested for efficiency, which was always over 0.80 (45) . Quantitative PCR was performed using a biology grade water and 5 μl of cDNA, with the exception of the reference genes, which were 157 determined using 2 μl of cDNA. In addition, amplifications were carried out with a systematic 158 negative control (NTC-no template control) containing no cDNA. Standard amplification parameters 159 contained an UDG pre-treatment at 50 °C for 2 min, an initial activation step at 95 °C for 10 min, 160 followed by 35 cycles: 15 s at 95 °C, 30 s at the annealing Tm and 30 s at 72 °C. 161
162
Statistical analyses 163
Based on extensive prior experience the hypothesised effect sizes of phenomic and transcriptomic 164 responses were expected to be >1.5x SD. Using this basis, the experimental power of the design was 165 calculated post-hoc using the "ANOVA: Fixed effects" test within the G-Power software 166 (http://www.gpower.hhu.de/). Using an a-value of 0.05 an average effect size of ~1.5x SD was 167 applied for key response variables (e.g. growth, net LC-PUFA gain, and Log2FC). As an example, a 168 power level (1-b) of 0.618 was determined for growth among diets A, B and C, whereas effect sizes 169 of other parameters were larger (e.g. net LC-PUFA gain had a power level (1-b) of 0.999). 170
For biochemical analyses, mean values were calculated for each tank prior to statistical analyses 171 (n = 3). Significance of differences was determined by one-way ANOVA followed when appropriate 172 by Tukey's post-hoc test using GraphPad InStat, Version 3.01 32 bit for Win95/NT (GraphPad 173 Software Inc., San Diego, CA, USA). For gene expression (n = 6), the relative expression levels (gene 174 expression fold-change) of the target genes, normalised to the three housekeeping genes, were 175 calculated following the method described by Pfaffl (46) . Data were tested for normality and 176 homogeneity of variances with Levene's test prior to one-way analysis of variance (ANOVA) 177 followed by Tukey's post-hoc test. The statistical analyses were performed using SPSS software 178 (IBM SPSS Statistics 23; SPSS Inc., Chicago, IL, USA). 179
180
Results
181
After 22 weeks, salmon fed the diets with essentially no EPA and DHA were less than half the weight 182 of fish fed the reference diet containing fish oil (Fig. 2) . While the fish fed the highest content of LA 183 had the lowest weight, there was no significant effect of ALA:LA ratio on growth after 22 weeks. 184
Mortality after the initial feeding phase was very low throughout the trial and unrelated to feed. 185
The aim of the present study was to very specifically quantify endogenous production of EPA 186 and DHA and not to quantify overall desaturation of ALA (and LA). Although 20:4n-3 satisfies our 187 definition of LC-PUFA (≥ C20 and ≥ 3 double bonds), it was not included in the calculations for total 188 LC-PUFA production in the present study. Similarly, 18:3n-6 and 20:3n-6 were not included in the 189 data for total n-6 LC-PUFA production. However, docosapentaenoic acid (DPA, 22:5n-3) was 190 included along with EPA and DHA in total n-3 LC-PUFA, and 22:4n-6 and 22:5n-6 were included 191 along with ARA in total n-6 PUFA (Figs. 3 & 4) . Full fatty acid compositions of whole fish after 22 192 weeks of being fed diets containing essentially no EPA and DHA are presented in Supplementary 193 Table 2 . 194
Salmon fed diets with ALA:LA ratios of 3:1, 1:1 and 1:3 contained 107, 80 and 41 mg of total n-195 3 LC-PUFA (EPA+DPA+DHA) per fish, almost all of which was the result of endogenous production 196 as initial first feeding fry contained just under 1 mg total n-3 LC-PUFA per fish (Fig. 3) . In the initial 197 fry, DHA and EPA was present with a ratio of 2:1, whereas in fry fed an ALA:LA ratio of 3:1 DHA 198 and EPA were in a ratio of over 2.6:1. This contrasted with the fish fed a standard commercial feed 199 containing EPA and DHA, where they accumulated 757 mg of total n-3 LC-PUFA, with DHA and 200 EPA in a ratio of 3.2:1 (Fig. 4) . Fry fed the highest amount of LA (ALA:LA of 1:3) accumulated 21 201 mg n-6 LC-PUFA, which compared to just over 28 mg in fish fed standard commercial feed, while 202 initial fry contained only 0.07 mg of ARA (Fig. 5) . 203
On a per fish basis, endogenous production of n-3 LC-PUFA was at least 5.9, 4.4 and 2.8 mg.g 204 fish -1 , and that of n-6 LC-PUFA was at least 0.2, 0.5 and 1.4 mg.g fish -1 in salmon fed diets with 205 ALA:LA ratios of 3:1, 1:1 and 1:3, respectively (Fig. 6 ). As daily (154 day trial) rates of production, 206 these data corresponded to at least 38.1, 28.4 and 18.2 µg.g fish -1 .day -1 for endogenous production of 207 n-3 LC-PUFA, and at least 1.4, 3.4 and 9.3 µg.g fish -1 .day -1 for n-6 LC-PUFA production in salmon 208 fed diets with ALA:LA ratios of 3:1, 1:1 and 1:3, respectively. The ratio of n-3 LC-PUFA production 209 to n-6 LC-PUFA production decreased from 27.4 to 2.0 as dietary ALA:LA ratio decreased and, 210 similarly, EPA:ARA and DHA:ARA ratios decreased as the dietary ratio of ALA:LA decreased. Less 211 obviously, and more interestingly, the DHA:EPA ratio increased from 2.6 to 5.3 as the dietary ratio 212 of ALA:LA decreased (Fig. 6) . 213
The distribution of the endogenously produced LC-PUFA in specific lipid classes and tissues was 214 also investigated. Comparing the proportion of fatty acids in total lipid and lipid classes, the 215 percentages of n-3 LC-PUFA and n-6 PUFA were higher in total phospholipids (PL) than in 216 triacylglycerols (TAG) (Fig. 7) . To compare the distribution among tissues, the level of the particular 217 fatty acid (DHA, EPA and ARA) in whole fish was compared with the levels in individual tissues. 218
Setting the reference level as the amount of n-3 LC-PUFA in whole fish fed the diet containing 219 ALA:LA at 3:1 (highest production), DHA was present at far higher levels in brain and also, to a 220 lesser extent, liver (Fig. 8 ). In contrast, EPA was present in higher amounts in liver and, to a lesser 221 extent, brain. With ARA, only liver showed a higher level than the reference, which was set as the 222 level in whole fish fed the diet containing ALA:LA at 1:3 (highest ARA production) (Fig. 8) . 223
Determination of the expression of key genes of LC-PUFA biosynthesis in liver by quantitative 224
RTPCR showed that transcript abundances of D6 (fadsd6) and D5 (fadsd5) fatty acyl desaturases and 225 elongase 2 (elovl2) were all significantly higher in fish fed the experimental feeds lacking LC-PUFA 226 (Fig. 8) . Although the differences were not statistically significant, expression levels of these genes 227 were numerically lower in fish fed the diet with balanced (equal proportions) of ALA and LA. In 228 contrast, diet did not affect the expression of elovl5a, and slightly reduced the expression of elovl5b 229 (Fig. 9 ). The expression of some genes related to lipid anabolic pathways, srebp1, srebp2 and fas, 230
showed increasing expression with increasing dietary LA (i.e. as ALA:LA decreased), while some 231 genes related to lipid catabolism, ppara, pparg and aco, showed the same pattern of expression among 232 the three experimental feeds with the lowest expression in fish fed the diet with an ALA:LA ratio of 233 1 (Fig. 9) . 234 235
Discussion 236
Although the fish fed the low ALA:LA ratio had the numerically lowest final weight there were no 237 significant differences between fish fed the experimental diets indicating that the dietary n-3 PUFA:n-238 6 PUFA ratio had little impact on growth. Of course, the fish fed the fishmeal-and fish oil-free feeds 239
were significantly smaller than fish fed the REF feed, which was entirely expected. The REF feed 240 was not a control feed in the present study, but simply a reference to place some of the data obtained 241 into context. It has already been demonstrated that salmon post-smolts can be grown on essentially 242 fishmeal and fish oil-free feeds without major impacts on growth using highly optimised feeds (47) (48) . 243
This was not the aim of the present trial, which was not a nutritional trial in terms of growth and feed 244 efficiency and was not testing ingredients, but was focussed entirely on nutrients and, specifically, 245 LC-PUFA. The experimental feeds were therefore formulated to supply nutrients at currently reported 246 requirement levels for Atlantic salmon (49) . In this respect, it is also important to clarify that the 247 experimental feeds were not essential fatty acid (EFA)-deficient despite containing no EPA, DHA or 248 ARA, as ALA and LA are reported to satisfy EFA requirements in salmonids (with complete LC-249 PUFA biosynthesis pathways) and the feeds contained ALA and LA at levels far above reported 250 requirement levels (49) . Certainly, the fish fed the experimental feeds showed none of the classical EFA 251 deficiency signs (50) . However, it is also known that LC-PUFA can supply EFA requirements at lower 252 levels and so the lack of LC-PUFA may indeed be part of the reason for the lower growth 253 obtained (51, 52) . However, the commercial start feed, as with the feeds used in the fishmeal-and fish 254 oil-free studies above, would undoubtedly be supplying many nutrients in excess of the minimal 255 levels reported in NRC (49) . Thus, it was expected that the experimental feeds would impact growth 256 and, hence, the reason to include the commercial feed (REF) to provide some context. Growth rate is 257 linked to metabolic activity including intermediary metabolism and key anabolic pathways such as 258 LC-PUFA biosynthesis and, therefore differences in growth rate could affect production rates per 259 fish. However, growth rate is less likely to affect production per g of fish and so data presented this 260 way should be unaffected by the differences in growth rate. 261
It had been shown previously that salmonids, Atlantic salmon and rainbow trout (Oncorhynchus 262 mykiss), can be net producers of n-3 LC-PUFA by feeding diets with only low levels of fish oil (53, 54) . 263
While no method for assessing in vivo production of LC-PUFA is perfect (55) , production of EPA and 264 DHA in these studies was calculated from total fatty acid intakes and final fatty acid contents in whole 265 fish using "fatty acid production value, FAVP" (56) or the whole body mass balance method (57) . The 266 present study used essentially similar methodology to these earlier studies except that the feeds were 267 fed from first feeding and contained essentially no LC-PUFA. This simplified the calculations as, 268 other than the very small amount of EPA, DHA and ARA in the alevins at first feeding, all the LC-269 PUFA present in the fish at the end of the trial was derived from endogenous biosynthesis. Feeding 270 diets with no EPA and DHA from first feeding had been done previously with rainbow trout, but 271 quantitative LC-PUFA production was not reported (58) . 272
The present study showed that in the trial period Atlantic salmon produced almost 6 mg n-3 LC-273
PUFA from ALA per g of fish (~40 µg.g fish -1 .day -1 ). There are some caveats to this figure. Firstly, 274 it should be regarded as a minimum amount, and cannot be lower, as it is highly likely that some LC-275 PUFA produced will be oxidised as demonstrated previously (54, 57, 59) . While endogenously produced 276 LC-PUFA may be less oxidised than dietary fatty acids, there is no biochemical/physiological 277 mechanism to prevent this oxidation (60) . Secondly, the data are limited to fry and the first half of the 278 parr (freshwater) stage and this could change over the entire life cycle. Biosynthesis of LC-PUFA 279 from 14 C-ALA was increased in hepatocytes of salmon undergoing parr-smolt transformation (61, 62) and, therefore, this could increase the capacity for endogenous production. Therefore, existing data 281 suggests 6 mg.g fish -1 is a minimum for production during the freshwater stage that may increase 282 prior to seawater transfer. There are few data on how the capacity for LC-PUFA biosynthesis is 283 affected by age per se and, indeed, this is identified as a gap in the knowledge for humans (63) . 284
However, there is evidence that the capacity for conversion of ALA to DHA is higher in human 285 infants than adults (64) . In salmon, based on assays of LC-PUFA production in hepatocytes it has been 286 speculated that activity may be lower in post-smolts in seawater (61, 62) , but there are no in vivo studies 287 to directly support this. 288
In humans, in vivo conversion of ALA to n-3 LC-PUFA has been estimated in a number of studies 289 including stable isotope studies and is generally very modest, with some low conversion to EPA with 290 conversion to DHA being even lower or not at all (63, 65, 66) . In fish, there are no previous studies that 291 provide equivalent data with which to directly compare the present results. However, in an in vivo 292 stable isotope study using 4-15 g rainbow trout fed 5 % fishmeal and 11 % vegetable oil, the rate of 293 DHA production was reported to be low at 0.54 µg.g fish -1 .mg ALA consumed -1 .day -1(67) . This 294 estimate is not directly comparable to the rate calculated in the present study. Extrapolating from data 295 calculated via the whole body fatty acid mass balance method, total ALA conversion could be 296 estimated at around 1.5 µg.g fish -1 .day -1 when rainbow trout were fed a high ALA diet (68) . While the 297 methodology used in the earlier trout trial was somewhat similar to that used in the present study, the 298 data are not directly comparable as the diets were formulated with fishmeal and contained ~ 1.5 % n-299 3 LC-PUFA (EPA:DHA ~1), and the presence of dietary DHA would reduce D6 desaturation of 300 ALA (69, 70) . 301
In humans, reducing dietary LA (increasing ALA:LA ratio) enabled increased conversion of ALA 302 to EPA and, in some cases, also increased DHA (63, 66) . The present study demonstrated how the dietary 303 ALA:LA ratio quantitatively impacted the overall production of both n-3 and n-6 LC-PUFA in 304 salmon. Thus, irrespective of dietary ALA:LA ratio, n-3 LC-PUFA production always exceeded n-6 305 LC-PUFA production, being 27-fold greater when dietary ALA exceeded LA by 2.6-fold, and it was 306 still 2-fold greater when fish were fed a diet with a 2.6-fold excess of LA. This demonstrates clearly 307 the preferences of enzymes in the LC-PUFA biosynthesis pathway for n-3 compared to n-6 fatty acid 308 substrates, confirming results from studies on enzyme activities determined with radiolabelled tracers 309 in hepatocytes (61) , preferences of individual desaturase and elongase proteins in heterologous 310 expression assays (71) , and by the whole body mass balance method (72) . While there are numerous 311 studies investigating the effects of dietary ALA:LA ratio in fish, few have attempted to quantify 312 impacts on LC-PUFA production. However, increasing dietary LA reduced n-3 LC-PUFA production 313 and increased n-6 LC-PUFA production in Murray cod (Maccullochella peelii peelii) (72) . In contrast, 314 while increasing dietary LA had a significant impact in increasing n-6 LC-PUFA production in 315 rainbow trout, it only marginally impacted n-3 LC-PUFA production (68) , reducing EPA production 316 but with little effect on DHA production (73) . A further noteworthy result in the present study was that 317 increased dietary LA (reduced ALA:LA ratio) also resulted in a reduction in overall LC-PUFA 318 production. The overall rate of LC-PUFA production decreased from around ~39.5 µg.g fish -1 .day -1
319
(38.1 n-3 + 1.4 n-6) in fish fed the high ALA:LA ratio to ~27.5 µg.g fish -1 .day -1 (18.2 + 9.3) in fish 320 fed the low ALA:LA ratio and, therefore, high dietary LA in effect inhibited the pathway. In contrast, 321 this was not observed in rainbow trout, where total LC-PUFA production was largely unaffected by 322 ALA:LA ratio (68) . Extrapolating from whole body fatty acid mass balance data, ~1.6 µg.g fish -1 .day -323 1 (1.5 ALA + 0.1 LA) to ~1.7 µg.g fish -1 .day -1 (1.4 + 0.3) of C18 PUFA were converted in fish fed 324 diets with high and low ALA:LA ratio, respectively (68) . 325
The optimal dietary DHA:EPA ratio and its relationship to tissue DHA:EPA ratios presents a 326 complicated situation and is poorly understood in salmon or, indeed, any species (59, 74) . The present 327 study aimed to provide some insight to the optimal dietary ratio of DHA:EPA by extrapolating from 328 the ratio actually produced endogenously in salmon when receiving no dietary input of preformed 329 EPA and DHA. One initial point to note is that the level of DHA in whole fish always exceeded that 330 of EPA and so the DHA:EPA ratio was always >1 in the present study. This was also the case in the 331 earlier study in rainbow trout fed a diet completely devoid of EPA and DHA (and an ALA:LA ratio 332 of around 1), where DHA:EPA ratio in both polar and neutral lipids in carcass, liver and intestine 333 varied between 1.3 in carcass neutral lipid to 4.1 in liver polar lipids (58) . However, interestingly, the 334 present study demonstrated that the DHA:EPA ratio produced through endogenous production of 335 EPA and DHA was not fixed, but affected by the dietary ALA:LA ratio and, thus, as dietary LA 336 increased, the DHA:EPA ratio also increased. While this is not something that had been highlighted 337 previously, careful examination of existing literature has shown that increased dietary LA (i.e. 338 reduced ALA:LA ratio) generally resulted in increased DHA:EPA ratios in whole fish and/or tissues 339 of a range of freshwater and salmonid species (68,73,75-81) , although not always (72, 82, 83) . It must be 340 stressed that the above results are not directly comparable with the present study as the fish in these 341 earlier trials were all fed diets that also contained EPA and DHA, complicating interpretation of the 342 data. However, a likely possible mechanism for the impact of dietary LA on DHA:EPA ratio is that 343 increased LA would increase competition with ALA for the LC-PUFA pathway (D6 desaturase) and 344 this could particularly impact production of EPA, but not the production of DHA from EPA to the 345 same extent. This explanation reflects the chemistry/biochemistry and enzyme kinetics of the 346 biosynthesis pathways in salmon (60, 71) , but an alternative explanation is that the result could possibly 347 reflect a physiological driver with DHA being "more essential" than EPA for membrane structure 348 and function (59) . In rats, the DHA:EPA ratio is highly dependent upon tissue with EPA > DHA in 349 blood and liver, but DHA greatly exceeding EPA in heart and brain, and dietary ALA and ALA:LA 350 ratio (no dietary EPA and DHA) had relatively little impact on tissue DHA:EPA ratios (84) . 351
While the above discussed quantitative and semi-quantitative data were the primary focus, the 352 present study also provided some additional insight into the fates of endogenously produced LC-353 PUFA. Irrespective of diet, the relative proportions of total LC-PUFA, EPA, DHA and ARA were all 354 higher in total phospholipids than in triacylglycerols as would be expected (60) . However, this pattern 355 was greatly enhanced in fish fed the experimental feeds compared to fish fed the reference diet, clearly 356 indicating that endogenously produced EPA, DHA and ARA were highly preferentially incorporated 357 into membrane phospholipids whereas greater proportions of dietary LC-PUFA are deposited in 358 storage lipid. To discriminate tissue preferences for the deposition of endogenously produced LC-359 PUFA, we compared the contents of individual tissues with the content in whole fish. Thus, tissues 360 showing higher contents per unit mass than whole fish indicates preferential deposition. This was 361 clearly observed in the high DHA content of brain, which reflected the known importance of DHA 362 in that tissue (60) . The only other tissue that showed higher contents of LC-PUFA was liver, likely 363 reflecting its key metabolic role in biosynthesis (28, 60) . Gene expression confirmed the active role of 364 liver in the biosynthesis of LC-PUFA with the expression of D6 and D5 fatty acyl desaturases and 365 elovl2 elongase all being upregulated in fish fed the experimental feeds devoid of EPA and DHA, 366 consistent with many previous studies in salmon (32, 71) . However, dietary ALA:LA ratio appeared to 367 have little effect suggesting that substrate levels were not a major driver of expression of these 368 genes (38) . Similarly, there was no effect of dietary ALA:LA ratio on the expression of D6 desaturase 369 and elovl5 elongase in liver of rainbow trout (68) . Dietary ALA:LA ratio affected the expression of D6 370 and D4 desaturases and elovl5 elongase in the marine rabbitfish (Siganus canaliculatus), which has 371 all the genes necessary for biosynthesis of EPA and DHA, but in a variable manner with no clear 372 pattern (81) . Interestingly, in the present study, brain showed relatively high contents of EPA in 373 addition to DHA, which may indicate in situ production of DHA in brain. However, it is not possible 374 to discriminate what proportion, if any, of brain DHA is actually the result of in-tissue production or 375 simply deposition of DHA produced elsewhere, such as liver (28, 60) . Furthermore, the fact that the high 376 content of DHA in brain was not also reflected in ARA content of brain was surprising (60) . 377
The increased expression of the lipid anabolic genes, sreb1, sreb2 and fas, as dietary ALA:LA 378 decreased was also unexpected. It is worth noting that the effect of diet on gene expression can be 379 looked at in two ways. Either that high dietary ALA and high ALA:LA ratio resulted in lower 380 expression, or that high dietary LA and low ALA:LA ratio increased expression. Irrespective, the 381 dietary effect does not have an obvious biochemical or physiological explanation. Similarly, while it 382 was also interesting that genes related to lipid catabolism, ppara, pparg and aco, all showed a similar 383 pattern of expression among the three experimental feeds, with lowest expression at a dietary 384 ALA:LA ratio of 1, the pattern was not readily explained. While it is perhaps noteworthy that the 385 expression of the D6 and D5 fatty acyl desaturases and elovl2 elongase also showed the same 386 expression pattern as for the lipid catabolism genes, it does not offer an explanation. Therefore, the 387 precise mechanism(s) underlying how dietary ALA:LA ratio affected the expression of lipid anabolic 388 and catabolic genes was not clear and requires further study. 389
The data obtained in the present study have provided a better understanding of the capacity for 390 LC-PUFA production in a vertebrate, Atlantic salmon, that has a complete biosynthetic pathway (via 391 the Sprecher shunt), and how dietary ALA and LA interact and affect LC-PUFA production. Salmon 392 farming is currently still largely dependent upon fish oil for provision of EPA and DHA, but levels 393 of fish oil in feeds continue to decline (85) resulting in reduced levels of EPA in DHA in farmed salmon 394 products (18) . Presently, around 70 % of oil in salmon feeds is supplied by vegetable oils that can only 395 supply C18 PUFA, LA and ALA (27) and, although there are potential new algal and GM-derived 396 sources of EPA and DHA on the horizon, it is uncertain exactly how these will be used (86) . Currently, 397 cost and availability restrict the use of these new sources, for the medium term at least, to being fish 398 oil replacements to maintain EPA and DHA at current levels, and not as vegetable oil replacements 399 and, therefore, salmon feeds will continue to contain high levels of vegetable oils. However, there are 400 many options with oils containing differing proportions of ALA and LA, and the data from the present 401 study enables the possibility to more precisely control dietary ALA and LA to maximise endogenous 402 production of EPA and DHA. 403
404
Conclusions 405
With a dietary n-3/n-6 PUFA ratio of 1:1, Atlantic salmon fry/parr can produce at least 4.4 mg n-3 406 LC-PUFA, with a DHA:EPA ratio of 3.4:1, per gram of fish. Production of n-3 LC-PUFA exceeded 407 that of n-6 LC-PUFA by almost 9-fold. Reducing the dietary n-3/n-6 PUFA ratio reduced n-3 LC-408 PUFA production, and EPA:ARA and DHA:ARA ratios, and increased n-6 LC-PUFA production, Fig. 9 
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